E-Cigarettes & Heated Tobacco Products: Harm Reducers or Youth Seducers? | Robert Anthenelli, MD
This presentation is part of the 2020 State of the Art in Addiction Medicine conference which covers an expansion of treatment into correctional health, hospital consultation services and emergency rooms. It will cover how, despite the pandemic, telehealth can reach those who are isolated. It will address the worrisome trends in fentanyl, methamphetamine, tobacco and benzodiazepines use; legalization of cannabis, treatment updates for youth, cannabis and alcohol in pregnant women; and novel treatments such as non-benzodiazepines for alcohol withdrawal and psychedelics for substance use disorders.
Learners cannot sign up for individual lectures, only for the full 2020 State of the Art in Addiction Medicine. Please contact CSAM (firstname.lastname@example.org) if you have any questions about this online educational offering.
Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care, psychiatry and other specialty field clinicians who want a better understanding of addiction and to improve their care of patients with unhealthy substance use
- Public policy makers, administrators and advocates who want an understanding of the current state of the field of addiction and its grater implications including towards prevention, access to care, integrated systems of care and healthcare technology
- Other healthcare professionals, including psychologists, therapists, nurses, and addiction counselors, who are involved in the treatment of patients with or at risk of substance use
- Examine the rapid growth of electronic nicotine delivery systems (ENDS) aka E-cigarettes and Heated Tobacco Products (HTPs) aka Heat-not-Burn Tobacco Products
- Describe evolution of e-cigarettes and Heat-not-Burn (HnB) Tobacco Products
- Discuss evidence whether they aid smoking cessation
- Describe alarming trend of greater use in teens
- Describe the effects of nicotine on the brain’s reward circuit and how that contributes to an addicted brain
Robert M. Anthenelli, MD
Dr. Anthenelli is a Professor in the Department of Psychiatry at the University of California (UC), San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He was previously the department’s Interim Chair, Executive Vice Chair, and Vice Chair for Veterans Affairs (VA), respectively, and Associate Chief of Staff for Mental Health at the VA San Diego Healthcare System. Prior to returning to UC San Diego in 2011, he was Professor of Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine and Cincinnati VA Medical Center where he founded and directed the Center for Treatment, Research & Education in Addictive Disorders and nationally acclaimed Cincinnati VA Substance Dependence Program.
The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco, alcohol, cocaine use, and comorbid psychiatric disorders by better understanding their neurobiology. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and University of California’s Tobacco-Related Disease Research Program. He has lectured widely across the globe and is the Principal Investigator and Publications Committee Co-Chair for the EAGLES trial – the largest placebo-controlled smoking cessation pharmacotherapy trial conducted to date.
DISCLOSURE: Dr. Anthenelli has disclosed he received grants for research support from Embera Neurotherapeutics and Pfizer.
The California Society of Addiction Medicine (CSAM) is accredited by the California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™, Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing education credit is available for psychologists, therapists, substance use counselors, nurses and physician assistants.
(see additional information on page for parent course)
- 0.75 AMA Category 1
- 0.75 Attendance